Fulgent Genetics, Inc. - Wutah pendapatan triwulanan FLGT

Simbol resmi perusahaan Fulgent (FLGT)

The quarterly revenue growth rate demonstrates the impact of stable contracts with clinics and insurers on capacity utilization for Fulgent Genetics, Inc. (FLGT). This trend is supported by management's strategy to diversify services beyond PCR diagnostics and return to core genetics. The relevance of precision medicine is driving product development, while 7.40 expresses the metric's value today, capturing the current trajectory of corporate sales.

FLGT (Fulgent Corp) riwayat Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 20.11.2026

Fulgent Corp (FLGT) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:Fulgent (FLGT)
Barang unggulan Fulgent Genetics Inc

To protect portfolio capital, it is critical to divest from assets exhibiting systemic degradation, using quarterly revenue growth rates as an indicator of operational resilience. This metric measures the speed of sales growth, which for Fulgent Genetics, Inc. (FLGT) reflects the demand for DNA testing and the level of insurance coverage; therefore, the trend in quarterly sales changes allows for the timely diagnosis of business stagnation.

Analisis perusahaan pesaing

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|LAB: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal cytekbio.com (CTKB)|OSUR (OraSure Corp) - Wutah pendapatan triwulanan|Exagen (XGN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Prenetics PRE|Insight Molecular (IMDX) - Tingkat wutah pendapatan sajrone kuartal|Trinity Biotech Corp - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal ProPhase PRPH|AIMD: Wutah pendapatan triwulanan|CODX - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Heart Test Laboratories, Inc.|Wutah pendapatan kuartal marang kuartal BMRA|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)